Press releases

Start / Newsroom / Press releases

2024-02-23 09:30 SpectraCure takes the next step in the work with the new clinical study Regulatory

2024-01-23 11:45 A well-accomplished annual audit in accordance with ISO 13485:2016

2023-12-19 08:30 Expert group comments on results of ongoing study Regulatory MAR

2023-11-16 15:30 SpectraCure has decided to seek approval for a clinical study of primary prostate cancer Regulatory MAR

2023-10-06 14:30 SpectraCure strengthens presence among urologists

2023-06-27 11:30 SpectraCure has been awarded an additional EU grant for industrialisation of the company's treatment system Q-PRO® Regulatory

2023-02-23 10:00 Approval for clinical study at Skåne University Hospital Regulatory

2023-02-02 14:40 Positive feedback from treatment with SpectraCure’s system Q-PRO® in New York Regulatory

2022-12-14 10:15 Masoud Khayyami has been appointed as interim CEO of SpectraCure Regulatory

2022-12-07 11:00 SpectraCure signs Letter of Intent with Cheplapharm Regulatory MAR